Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Promatix offers design to installation services and develops cancer therapies using bispecific antibodies
Innovative Solution
Promatix offers services ranging from design to installation and specializes in developing cancer therapies using bispecific antibodies. The company engages in biopharmaceutical research, antibody engineering, clinical trial support, and therapeutic development.
Investment Funding
Revenue
$1M to $10M
About
Promatix offers services ranging from design to installation and specializes in developing cancer therapies using bispecific antibodies. The company engages in biopharmaceutical research, antibody engineering, clinical trial support, and therapeutic development. Additional services include molecular diagnostics, customized assay development, and bioinformatics analysis, supporting innovation in oncology and personalized medicine.
Products
Demo Product or Complete Product?
Complete product / commercially available
Something missing or incorrect on this page? Help us enrich this information
